Your browser doesn't support javascript.
loading
Lower Incidence of Hypoglycemia With Angiotensin Receptor Blocker Versus ACE Inhibitor Therapy in People With or Without Diabetes.
Khanimov, Israel; Zingerman, Boris; Rozen-Zvi, Benaya; Shimonov, Mordechai; Leibovitz, Eyal.
Afiliación
  • Khanimov I; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Zingerman B; Department of Nephrology at the Hasharon Campus, Rabin Medical Center, Petah Tikva, Israel.
  • Rozen-Zvi B; Department of Nephrology at the Hasharon Campus, Rabin Medical Center, Petah Tikva, Israel.
  • Shimonov M; Department of Surgery A, Edith Wolfson Medical Center, Holon, Israel.
  • Leibovitz E; Department of Internal Medicine A, Yoseftal Medical Center, Eilat, Israel.
Clin Diabetes ; 42(2): 300-307, 2024.
Article en En | MEDLINE | ID: mdl-38694239
ABSTRACT
This article describes a study examining the association between treatment with ACE inhibitors or angiotensin receptor blockers (ARBs) and incident hypoglycemia in patients with or without diabetes who were admitted to the internal medicine departments of a tertiary hospital in the Tel Aviv district of Israel. The authors found that treatment with ARBs, but not ACE inhibitors, compared with treatment with neither, was associated with a reduced risk of hypoglycemia regardless of diabetes status.

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Clin Diabetes Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Clin Diabetes Año: 2024 Tipo del documento: Article